Ketoconzole indications and usage

Revision as of 02:46, 8 January 2014 by Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Ketoconazole}} {{CMG}}; {{AE}} {{AZ}} ==Indications and Usage== Ketoconazole tablets USP, 200 mg should be used only when other effective antifungal therapy is n...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Ketoconzole
Ketoconazole® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Indications and Usage

Ketoconazole tablets USP, 200 mg should be used only when other effective antifungal therapy is not available or tolerated and the potential benefits are considered to outweigh the potential risks.

Ketoconazole tablets USP, 200 mg are indicated for the treatment of the following systemic fungal infections in patients who have failed or who are intolerant to other therapies: blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. Ketoconazole tablets USP, 200 mg should not be used for fungal meningitis because it penetrates poorly into the cerebrospinal fluid.[1]

References

  1. "KETOCONAZOLE TABLET [TARO PHARMACEUTICALS U.S.A., INC.]".

Adapted from the FDA Package Insert.